专栏名称: 药时代
药时代,原医药研发社交平台,致力于成为中国医药研发界朋友们知识拓展、思想碰撞、合作共赢的高科技自媒体家园,和文字、音频、视频频频俱到的多媒体平台。线上互动与线下活动有机结合,跨界创新。热烈欢迎您关注药时代,共同谱写中国医药研发新时代!
目录
相关文章推荐
新疆药品监管  ·  从哪吒“重生”说起:莲的药用价值 ·  2 天前  
51好读  ›  专栏  ›  药时代

人工智能助力临床试验招募!TD2和Deep 6 AI 宣布合作以加速肿瘤临床试验受试者招募

药时代  · 公众号  · 药品  · 2017-06-03 00:20

正文

前 言

人工智能 ,Artificial Intelligence,已成为一道亮丽的风景线而吸引人们的注意力。比尔·盖茨先生在谈到当下能对世界产生巨大影响的机会时推荐三个领域——人工智能、能源以及生物科学。因为人工智能可以使人们生活更有效率和具有创造力。我们药时代一直关注人工智能在医药研发领域的应用,分享过多篇文章。



今天,我们向朋友们推荐的是 人工智能助力临床试验受试者招募 ,希望帮助临床试验 更加精准,成功的几率更高 。TD2和Deep 6 AI 这两家公司宣布建立合作伙伴关系,以加速肿瘤临床试验受试者招募。欢迎朋友们阅读新闻稿,了解详情!

新闻稿





TD2 and Deep 6 AI Announce Partnership to Accelerate Oncology Clinical Trial Recruitment


Artificial intelligence used to identify potential clinical trial participants in minutes


SCOTTSDALE, Ariz. and PASADENA, Calif. (May 31, 2017) Translational Drug Development (TD2 ) and Deep 6 AI announced today a formal agreement to work together in the fields of oncology and fibrosis to rapidly match eligible patients with appropriate clinical trials.


The partnership grants TD2—an oncology development organization—access to cutting-edge artificial intelligence provided by Deep 6 AI, a company dedicated to finding patients for clinical trials. With the ability to analyze all structured and unstructured clinical data, including physician notes and pathology and genomic reports, Deep 6 AI’s system expedites the process of matching patients with new drug trials—finding suitable participants in minutes rather than the months it takes to manually review patient records.







请到「今天看啥」查看全文